HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naohisa Uchimura Selected Research

HLA-DQB1 antigen (HLA DQB1)

1/2022Genome-wide association study of idiopathic hypersomnia in a Japanese population.
12/2018A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.
2/2015New susceptibility variants to narcolepsy identified in HLA class II region.
1/2015An association analysis of HLA-DQB1 with narcolepsy without cataplexy and idiopathic hypersomnia with/without long sleep time in a Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naohisa Uchimura Research Topics

Disease

19Schizophrenia (Dementia Praecox)
07/2018 - 03/2007
15Sleep Initiation and Maintenance Disorders (Insomnia)
03/2024 - 06/2002
14Psychotic Disorders (Schizoaffective Disorder)
10/2011 - 08/2008
7Narcolepsy
04/2022 - 01/2015
6Restless Legs Syndrome (Restless Legs)
11/2013 - 01/2010
5Disorders of Excessive Somnolence (Hypersomnia)
12/2018 - 06/2010
4Sleep Wake Disorders
02/2015 - 01/2006
4Mental Disorders (Mental Disorder)
06/2012 - 03/2011
3Sleep Apnea Syndromes (Sleep Apnea)
01/2022 - 06/2010
3Cataplexy
12/2018 - 01/2015
3Sleepiness
11/2018 - 08/2009
3Major Depressive Disorder (Major Depressive Disorders)
01/2016 - 06/2010
2Chronic Obstructive Pulmonary Disease (COPD)
09/2023 - 05/2013
2Obstructive Sleep Apnea
09/2023 - 06/2010
2Idiopathic Hypersomnia
04/2022 - 01/2015
2Nocturia
01/2021 - 01/2016
2Delirium
12/2019 - 03/2014
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2018 - 01/2016
2Alzheimer Disease (Alzheimer's Disease)
09/2013 - 02/2013
2Genetic Predisposition to Disease (Genetic Predisposition)
03/2011 - 08/2010
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
02/2011 - 06/2002
1Exanthema (Rash)
07/2022
1Mood Disorders (Mood Disorder)
07/2022
1Treatment-Resistant Depressive Disorder
01/2021
1Acute Disease
12/2019
1Cognitive Dysfunction
10/2018
1Substance-Related Disorders (Drug Abuse)
10/2018
1Dementia (Dementias)
03/2014
1Asthma (Bronchial Asthma)
01/2013
1Dysgeusia (Parageusia)
12/2012
1Parathyroid Diseases (Parathyroid Disorders)
01/2012
1Depressive Disorder (Melancholia)
01/2012
1Thyroid Diseases (Thyroid Disease)
01/2012
1Chronic Hepatitis C
01/2012
1Hypertension (High Blood Pressure)
12/2011
1Somnambulism (Sleepwalking)
10/2011
1Human Influenza (Influenza)
10/2011

Drug/Important Bio-Agent (IBA)

15Methamphetamine (Desoxyn)FDA LinkGeneric
10/2011 - 08/2008
6Antipsychotic Agents (Antipsychotics)IBA
12/2017 - 01/2006
5ramelteon (Rozerem)FDA Link
03/2024 - 02/2011
5BenzodiazepinesIBA
03/2024 - 01/2006
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 02/2015
4HLA-DQB1 antigen (HLA DQB1)IBA
01/2022 - 01/2015
3Hypnotics and Sedatives (Sedatives)IBA
03/2024 - 01/2006
3Eszopiclone (Lunesta)FDA Link
03/2024 - 06/2012
3Zolpidem (Ambien)FDA LinkGeneric
03/2024 - 01/2006
3Antidepressive Agents (Antidepressants)IBA
01/2021 - 06/2010
3Hemoglobins (Hemoglobin)IBA
07/2018 - 01/2014
3Serotonin (5 Hydroxytryptamine)IBA
05/2013 - 02/2010
3Pramipexole (Mirapex)FDA LinkGeneric
01/2011 - 01/2010
2Melatonin Receptors (Melatonin Receptor)IBA
03/2024 - 02/2011
2Orexin Receptor AntagonistsIBA
03/2024 - 07/2022
2lemborexantIBA
03/2024 - 09/2023
2suvorexantIBA
03/2024 - 12/2019
2Biomarkers (Surrogate Marker)IBA
01/2018 - 05/2013
2Memantine (Namenda)FDA Link
09/2013 - 02/2013
2N-Methylaspartate (NMDA)IBA
09/2013 - 08/2009
21- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA
01/2013 - 03/2012
2Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2011 - 08/2010
2EnzymesIBA
03/2011 - 02/2005
2Glutamic Acid (Glutamate)FDA Link
03/2011 - 08/2009
1zopiclone (Zop)IBA
03/2024
1salicylhydroxamic acid (SHAM)IBA
01/2023
1Orexin ReceptorsIBA
07/2022
1TS-142IBA
07/2022
1Lamotrigine (Lamictal)FDA LinkGeneric
07/2022
1OrexinsIBA
04/2022
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2022
1KetamineFDA LinkGeneric
01/2021
1Temazepam (Nocturne)FDA LinkGeneric
01/2021
1GABA-A Receptor AgonistsIBA
10/2018
1imidafenacinIBA
01/2016
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2016
1HLA-DRB1 Chains (HLA DRB1)IBA
10/2015
1CC ChemokinesIBA
10/2015
1Aripiprazole (Abilify)FDA Link
02/2015
1Quetiapine Fumarate (Seroquel)FDA Link
03/2014
1Risperidone (Risperdal Consta)FDA LinkGeneric
03/2014
1Haloperidol (Haldol)FDA LinkGeneric
03/2014
1rotigotineFDA Link
11/2013
1Excitatory Amino Acid AntagonistsIBA
09/2013
1MethoxyhydroxyphenylglycolIBA
05/2013
1Hydroxyindoleacetic AcidIBA
05/2013
1Homovanillic AcidIBA
05/2013
1AcidsIBA
05/2013
1AdiponectinIBA
01/2013
1Oxyhemoglobins (Oxyhemoglobin)IBA
01/2013
1Oxygen (Dioxygen)IBA
08/2012
1Carbon DioxideIBA
08/2012
1Pharmaceutical Sleep AidsIBA
07/2012
1InterferonsIBA
01/2012
1ElectrolytesIBA
01/2012
1Ribavirin (Virazole)FDA LinkGeneric
01/2012

Therapy/Procedure

8Therapeutics
03/2024 - 12/2011
5Drug Therapy (Chemotherapy)
01/2022 - 06/2010
3Continuous Positive Airway Pressure
01/2022 - 06/2010
2Drug Tapering
10/2018 - 06/2002
1Duration of Therapy
01/2016
1Home Nursing (Nursing, Home)
03/2014
1Exercise Therapy (Therapy, Exercise)
12/2011